Exenatide
The Potential of Dapagliflozin Plus Exenatide in Obese Insulin-resistant Patients
AstraZeneca · Phase 3 · Terminated · Enrollment 13
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Exenatide
AstraZeneca · Phase 3 · Terminated · Enrollment 13
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.